Release Date: 27/08/14 13:30 Summary: CBX: Supplementary Bidders Statement - Off-market bid Price Sensitive: Yes Download Document 176.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%